You are here

Prof. Vos and Dr Hyndryckx - New therapies in UC

Dr Gent

Two colleagues from UZ Ghent, Prof. Vos and Dr Hyndryckx, discuss two eagerly awaited trails: the TURANDOT trial looking at the safety and safety and efficacy of anti-MAdCAM antibodies; and a study focusing on the use of methotrexate in corticosteroid-dependent patients with ulcerative colitis (UC).



Subscribe to our E-Alert to stay informed of all new content as it's published on this platform.

IBD 13.03.2015

Visit the journal website!

Search form